An overview of Canadian and U.S. approaches to drug regulation and responses to postmarket adverse drug reactions. [electronic resource]
Producer: 20131126Description: 313-20 p. digitalISSN:- 1932-2968
- Canada
- Diabetes Mellitus, Type 2 -- drug therapy
- Drug and Narcotic Control -- legislation & jurisprudence
- Humans
- Hypoglycemic Agents -- therapeutic use
- Patient Safety -- legislation & jurisprudence
- Product Surveillance, Postmarketing -- methods
- Rosiglitazone
- Thiazolidinediones -- therapeutic use
- United States
- United States Food and Drug Administration -- legislation & jurisprudence
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.